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Abstract 
Chronic pain is associated with maladaptive reorganization of the central nervous system. Recent 
studies have suggested that disorganization of large-scale electrical brain activity patterns, such 
as neuronal network oscillations in the thalamocortical system, plays a key role in the 
pathophysiology of chronic pain. Yet, little is known about whether and how such network 
pathologies can be targeted with noninvasive brain stimulation as a nonpharmacological 
treatment option. We hypothesized that alpha oscillations, a prominent thalamocortical activity 
pattern in the human brain, are impaired in chronic pain and can be modulated with transcranial 
alternating current stimulation (tACS). We performed a randomized, crossover, double-blind, 
sham-controlled study in patients with chronic low back pain (CLBP) to investigate how alpha 
oscillations relate to pain symptoms for target identification and whether tACS can engage this 
target and thereby induce pain relief. We used high-density electroencephalography to measure 
alpha oscillations and found that the oscillation strength in the somatosensory region at baseline 
before stimulation was negatively correlated with pain symptoms. Stimulation with alpha-tACS 
compared to sham (placebo) stimulation significantly enhanced alpha oscillations in the 
somatosensory region. The stimulation-induced increase of alpha oscillations in the 
somatosensory region was correlated with pain relief. Given these findings of successful target 
identification and engagement, we propose that modulating alpha oscillations with tACS may 
represent a target-specific, nonpharmacological treatment approach for CLBP. This trial has been 
registered in ClinicalTrials.gov (NCT03243084). 
 
Perspective 
This study suggests that a rational design of transcranial alternating current stimulation, which is 
target identification, engagement, and validation, could be a nonpharmacological treatment 
approach for patients with CLBP. 
Key words 
Chronic low back pain, electroencephalography, alpha oscillations, transcranial alternating 
current stimulation 
  
brought to you by COREView metadata, citation and similar papers at core.ac.uk
provided by Carolina Digital Repository
Chronic pain is associated with pathological changes in neuronal activity over somatosensory, 
insular, cingulate, and prefrontal cortices.46 These brain regions play a fundamental role in the 
processing of pain.32, 51,57 Several electroencephalography (EEG) and 
magnetoencephalography (MEG) studies have shown that patients with chronic pain exhibit 
abnormal neuronal oscillations.43, 55 In particular, pathologically increased theta oscillations 
(4–8 Hz)34, 48,49, 53,58 have motivated a conceptual framework of thalamocortical 
dysrhythmia (TCD) in chronic pain.33, 34 Moreover, the peak frequency of neuronal oscillations 
measured by EEG and MEG appears lower in patients with chronic pain when compared to 
healthy control participants.48, 49,53, 56,58 Thus, these findings imply that identifying the 
relationship between neurophysiological changes and pain severity and engaging the identified 
target could represent a network-level approach to understand a causal role of chronic pain. Yet, 
little is known about whether and how such network pathologies can be modulated with targeted 
noninvasive brain stimulation in patients with chronic pain. 
 
Here, we performed a randomized, crossover, double-blind, sham-controlled clinical trial to 
investigate how noninvasive brain stimulation can target neuronal oscillations in patients with 
chronic pain. We chose to investigate target identification and engagement of neuronal 
oscillations in a sample of patients with chronic low back pain (CLBP), which is the single 
leading cause of disability worldwide.22 We built a model of a bifrontal stimulation-electrode 
montage to target and modulate the bilateral somatosensory cortex in patients with CLBP 
because previous studies have shown that abnormal neuronal oscillations in the somatosensory 
cortex reflect pain perception.13, 20,45, 46,60 In addition, previous brain stimulation 
approaches, such as deep brain stimulation and repetitive transcranial magnetic stimulation 
(rTMS), successfully targeted the somatosensory cortex to reduce pain severity.6, 31,47 Inspired 
by these successful approaches and the fundamental role of somatosensory cortex in pain, we 
built a model bifrontal montage to target the somatosensory cortex. 
 
We formulated 2 hypotheses in our study. First, patients with CLBP exhibit impaired alpha 
oscillations. This hypothesis is based on previous findings that pain perception suppresses alpha 
oscillations23, 24,45 and the suppression is correlated with pain severity.7, 9,25, 40,52 Second, 
transcranial alternating current stimulation (tACS), which is a noninvasive brain stimulation tool 
that can modulate neuronal oscillations by applying oscillating electrical currents,21, 54 can 
enhance alpha oscillations in the somatosensory cortex and thereby induce pain relief. We 
recorded alpha oscillations by high-density EEG to investigate the hypothesized association of 
alpha oscillations with pain severity in patients with CLBP and applied 10-Hz tACS based on the 
identified target region. We assessed pain severity and perceived disability related to CLBP with 
two self-report rating scales. We found that alpha oscillations in the somatosensory region were 
negatively correlated with pain severity. Furthermore, 10-Hz tACS applied in the somatosensory 
region enhanced alpha oscillations and the enhancement correlated with pain relief. Our findings 
of successful target identification and engagement with tACS suggest that applying noninvasive 





Both male and female participants (age 18–65) were recruited from local pain and physical 
therapy clinics in Chapel Hill, NC area. Inclusion criteria consisted of a diagnosis of CBP by a 
licensed clinician, pain severity ≥3 on a 0–10 numerical pain rating scale,11 and duration of 
CLBP for at least 6 months (Table 1). All participants signed a consent form. Eligibility of 
participants was determined by a telephone screening before the first session. Twenty 
participants participated in 2 sessions (10-Hz tACS and sham) separated by 1 to 3 weeks and 
intervention sequence was randomized and balanced across all participants. Randomization was 
performed using sequentially numbered assignment. One of the authors (J.H.P.) generated the 
random allocation sequence, enrolled all participants, and assigned the participants to the 
sequence. 
 
Table 1. Demographic Information 
 
Participants (n = 20) 
Gender (M/F) 8/12 
BMI 25.9 ± 4.3 
Duration of CLBP, mo 84.8 ± 70 
DVPRS, baseline 4.4 ± 1.0 
ODI, baseline 22.7 ± 11.2 
Race (Caucasian/African American) 18/2 
Ethnicity (Hispanic/Not Hispanic) 1/19 
Education level 
 
 High school or equivalent 3 
 Associate's or Bachelor's degree 9 
 Advanced degree 8 
NOTE. Data are reported as mean ± SD. 
Study Design 
We performed a randomized, crossover, double-blind, sham-controlled, clinical trial with 2 
stimulation conditions (10-Hz tACS and sham). The study was performed at the University of 
North Carolina at Chapel Hill (ClinicalTrials.gov, NCT03243084) and approved by the 
Biomedical Institutional Review Board of the University of North Carolina at Chapel Hill. 
Behavioral questionnaires were administered before and after the stimulation at each session. All 
participants completed the Defense and Veterans Pain Rating Scale (DVPRS)8 and Oswestry 
Disability Index (ODI)18 to assess the severity of chronic low back pain and perceived 
disability, respectively. The DVPRS comprises a validated numerical rating pain scale (0–10) 
with detailed verbal descriptions and facial expressions. We used the back pain-specific ODI, 
which consists of 10 questions pertaining to perception of disability in daily life activities. 
Although participants completed both self-report measures at the beginning of each session, 
participants only completed the DVPRS immediately after stimulation. Because the ODI 
encompasses questions about daily living, the follow-up was taken 2 days after each session for a 
more valid measure of any disability change. EEG data were recorded from participants with 
their eyes closed for 2 minutes before the stimulation and with their eyes open before and after 
the stimulation for 2 minutes. EEG signals were recorded using a 128-channel Geodesic EEG 
system (EGI Inc, Eugene, OR) at a sampling rate of 1 kHz. Electrode Cz and one electrode 
between Cz and Pz were used as the reference and as the ground, respectively. Instructions for 
the tasks were implemented in Presentation (Neurobehavioral Systems, Inc, Berkeley, CA). 
Participants were instructed by a computer voice to fixate on a crosshair and open their eyes 
while staying relaxed for the eyes-open condition. Here we report on the primary and secondary 
outcomes with regard to modulation of alpha oscillations and associated changes in pain 
symptoms. Results on heart rate variability will be reported elsewhere. The sample size was 
determined by the amount of funding available for the grant that supported this work. The study 
was performed between September and December 2017. Twenty of twenty-one participants 
completed the study after enrolling (1 participant dropped out due to a scheduling conflict). We 
here report on the 20 study completers. The trial was ended when the target of 20 participants 
completing both sessions was reached. CONSORT diagram is provided in supplementary 
materials. The study protocol will be made available in response to written request to the 
corresponding author (F.F.) 
 
tACS 
We applied 3 carbon-silicone electrodes to the scalp with Ten20 conductive paste (Bio-Medical 
Instruments, Clinton Township, MI) and used the XCSITE 100 stimulator (Pulvinar Neuro LLC, 
Chapel Hill, NC) to administer tACS. Five-digit codes were used to ensure blinding of the study 
coordinators with regard to the stimulation conditions. The XCSITE 100 device does not display 
any information that would provide insights into whether verum or sham stimulation is applied. 
Two of the three electrodes (5 × 5 cm each) were placed at F3 and F4 according to 10-20 
international coordinate system and these 2 electrodes were connected together for 10-Hz tACS. 
The other electrode (5 × 7 cm) was placed at Pz as a “return” electrode. Stimulation montage and 
modeling of electric field distribution were calculated with the tES LAB 1.0 software (Neurophet 
Inc, Seoul, South Korea) as depicted in Fig 1. In this software, we used a T1-weighted MRI 
(adult male) from the human connectome project.14 The MRI data were segmented by 8 tissues 
(cerebrum gray matter, cerebrum white matter, cerebellar gray matter, cerebellar white matter, 
ventricles, cerebrospinal fluid, skull and skin) and each tissue was assigned isotropic 
conductivity values.29 To obtain electric field distributions, we used the finite element method 
with tetrahedron volume meshes. The number of tetrahedron mesh was ∼4.3 million and the 
quasi-static Maxwell's equation was used. The 2 electrodes placed at the frontal lobe delivered an 
in-phase sinusoidal waveform with 1 mA amplitude each (zero-to-peak). Stimulation duration 
was 40 minutes for both conditions. Verum stimulation delivered 40 minutes of 10-Hz tACS 
with 10 seconds of ramp-up and ramp-down. Sham stimulation delivered 10 seconds of ramp-up, 
followed by 60 seconds of 10-Hz tACS, followed by 10 seconds of ramp-down for a total of 80 
seconds. The choice of such an “active sham” is an established strategy to enhance blinding of 
the participants to the stimulation condition. To confirm successful blinding, participants were 
asked to fill out a questionnaire how sure they were of receiving stimulation on a visual analog 
scale (0–100) after each stimulation session. We found no significant difference of the visual 
analogue scale between the 2 stimulation conditions (P = .1555, Wilcoxon signed rank test; 
supplementary Fig 1). On average, the stimulation sessions were spaced by 14.4 ± 6.5 days. 
During the stimulation, all participants were seated comfortably and watched Reefscapes 
(Undersea Productions, Queensland, Australia) that displays tropical fish underwater scenes to 
minimize the phosphenes induced by stimulation. Participants were asked to stay relaxed, watch 
the video, and keep their eyes open.  
 
Figure 1. Stimulation montage, waveforms, and distributions of electric field in the brain. (A) 
Electrodes E1 and E2 delivered in-phase 10-Hz tACS with 1mA amplitude (zero-to-peak). 
Electrode E3 was used as the return electrode. (B) Normalized electric field distribution (V/m) 
by bifrontal 10-Hz tACS (top-view and left-top-view) in grey and white matter.  
EEG Analysis and Statistical Testing 
Off-line processing was performed by EEGLAB,12 FieldTrip,42 and custom-built scripts in 
MATLAB. First, all data were downsampled to 250 Hz with anti-aliasing filtering and bandpass 
filtered from 1 to 50 Hz. Second, the data were preprocessed by an artifact subspace 
reconstruction algorithm39 to remove high-variance and reconstruct missing data. Briefly, the 
algorithm first finds a minute of data that represents clean EEG as a baseline. Then, principle 
component analysis is applied to the whole data set with a sliding window to find the subspaces 
in which there is activity that is more than 5 standard deviations away from the baseline EEG. 
Once the function has identified the outlier subspaces, it treats them as missing data and 
reconstructs their content using a mixing matrix that is calculated from the clean data. Third, bad 
channels that were found in the previous step were interpolated and common average referencing 
was performed. Fourth and lastly, infomax independent component analysis26 was performed to 
remove eye blinking, eye movement, muscle activity, heartbeats, and channel noise. All 
independent component analysis components were visually inspected and components were 
manually selected for rejection. These initial preprocessing steps were carried out on the full 
EEG dataset before unblinding of the study. 
 
Resting-state EEG data were epoched into 2-second windows. Each epoch was visually 
inspected in the temporal domain and bad epochs that contained abnormal spikes or high-
frequency noise were removed. Power spectral density (PSD) was computed by Welch's method 
with a 2-second window and a 12.5% overlap resulting in a PSD with 0.5-Hz frequency bins. 
Individual alpha frequency (IAF), which we defined as the frequency of peak power in the 
occipital alpha (8–12 Hz) from eyes-closed EEG data, was selected for each participant. The 
power of the alpha oscillations was obtained by averaging of the PSD around the IAF 
(IAF−1Hz≤IAF≤IAF+1Hz) and the alpha oscillations were normalized by the average of all 
electrodes to minimize the intersubject variability of alpha oscillations.1, 2 Thirty-eight 
electrodes outside of the scalp were excluded and the remaining 90 electrodes inside of the scalp 
were used for topographical representation. 
 
For statistical testing, we used a linear mixed-model analysis with fixed factors of “condition” 
(tACS and sham), “session” (session1, session2), and “sequence” (tACS-sham, sham-tACS), 
with random factor “participant” written in R (R Foundation for Statistical Computing, Vienna, 
Austria). We assumed that no carryover effect was observed because there were sufficient 
washout periods between the 2 sessions and outlasting treatment effects of stimulation are 
negligible. Kenward–Roger approximations were used to perform F-tests for each factor and 
interaction and obtain P values. Post hoc statistical tests were performed using student's t-test 
across participants at each electrode and it was corrected by false discovery rate (FDR).5 
Changes of measured values over sessions were quantified with a modulation index (MI): 
MI(a,b)=(a−b) / (a+b). 
Changes in spatially-normalized alpha oscillations were calculated by 
MI(Alphaafter, Alphabefore). In contrast, changes in DVPRS and ODI were calculated 
by MI(DVPRSbefore, DVPRSafter) and MI(ODIbefore, ODIafter),  respectively. Given the non-
normal distribution of the modulation indices for the assessments, we also performed exploratory 
analysis using the Wilcoxon signed rank test. 
 
Results 
Pain Assessments and Endogenous Alpha Oscillations 
We first examined how endogenous alpha oscillations were correlated with CLBP severity 
measured by the DVPRS and ODI, ie, target identification. Baseline spatially-normalized alpha 
oscillations were calculated from 2-minute eyes-open data at the first study session regardless of 
the stimulation condition for that session. We calculated the Spearman's rho between the baseline 
alpha oscillations and the assessments across all participants at each scalp EEG channel. We 
found significant negative correlations over the bilateral and left somatosensory region for the 
DVPRS and ODI, respectively (Fig 2A). The black dots represent EEG channels with 
statistically significant correlations (P < .05, FDR-corrected). Negative correlations indicate 
endogenous alpha oscillations were lower for patients with higher pain severity (DVPRS) and 
higher perceived disability (ODI). Given the similarity in the topographic distribution of these 
correlations, we confirmed that the DVPRS and ODI scores were positively correlated (r = .6375, 
P = .0025; Fig 2B). These results suggest that reduced endogenous alpha oscillations could 
represent the severity of CLBP and its impact on the perceived disability.  
 
Figure 2. Correlations between baseline alpha oscillations and clinical assessments(DVPRS and 
ODI). (A) Topographical distribution for DVPRS and ODI. Small black dots represent EEG 
channels with statistical significance ( P < .05, FDR-corrected). (B) Scatter plot for correlated 
ODI and DVPRS (rho = .6375, P = .0025). 
Enhanced Alpha Oscillations by 10-Hz tACS 
Our finding that a reduction in alpha oscillations is associated with pain severity in CLBP 
suggests that tACS could restore these pathological reduced oscillations. Thus, we next 
examined modulation, ie, target engagement, of endogenous alpha oscillations by 40 minutes of 
bifrontal 10-Hz tACS and sham stimulation. Changes in spatially-normalized alpha oscillations 
from eyes-open data for 2 minutes were obtained immediately before and after stimulation for 
conditions. The increase in alpha oscillations was significantly higher in the 10-Hz tACS 
condition (Fig 3, left) compared to the sham condition (Fig 3, middle; F1,18 = 6.5, P = .02). The 
black dots in the topographic map (Fig 3, right) represent the location of EEG channels with 
statistically significant differences in modulation of alpha oscillation between 10-Hz tACS and 
sham, (P < .05, FDR-corrected). These results suggest that 10-Hz tACS selectively enhanced 
endogenous alpha oscillations over the somatosensory region in patients with CLBP.  
 
Figure 3. Averaged topographical distribution of changes in spatially-normalized alpha 
oscillations for tACS (left), sham (middle), and the difference (right). Individual alpha frequency 
was used (IAF ± 1 Hz) and small black dots represent EEG channels with statistical significance 
(P < .05, FDR-corrected). 
Changes in Pain Assessments and Alpha Oscillations 
Given the correlation between a reduction of alpha oscillations and pain severity, we next asked 
whether the stimulation-induced changes in alpha oscillations modulated pain severity. We 
examined how enhanced alpha oscillations by 10-Hz tACS were correlated with changes in pain 
severity. We calculated the Spearman's rho between changes in spatially-normalized alpha 
oscillations, MI(Alphaafter, Alphabefore), and the 2 assessments MI(DVPRSbefore, DVPRSafter), 
MI(ODIbefore, ODIafter) for each stimulation condition at each EEG channel. We found significant 
positive correlations over the somatosensory and frontal regions for the DVPRS in the 10-Hz 
tACS condition (Fig 4, top row). The black dots in the topographic map represent statistically 
significant EEG channels (P < .05, FDR-corrected). In contrast, no significant correlations were 
obtained in the sham condition for the DVPRS. Similarly, for the ODI, we found significant 
positive correlations over the left somatosensory and frontal regions (P < .05, FDR-corrected) in 
the 10-Hz tACS condition and no significant correlations in the sham condition. Thus, increasing 
alpha oscillations reduced pain severity and perceived disability, which suggests a causal of 
pathological reduced alpha oscillations in CLBP. 
 
 
Figure 4. Topographical distribution of correlations between enhanced alpha oscillations and 
pain symptom changes. Small black dot represent EEG channels with statistical significance (P < 
.05, FDR-corrected). 
Clinical Improvement of CLBP 
As secondary outcome, we determined the improvement in the DVPRS and ODI scores 
independent of the neurophysiological changes. We calculated changes of the 2 assessments 
(DVPRS and ODI) by using the modulation indices MI (DVPRSafter, DVPRSbefore) and MI (ODIafter, 
ODIbefore) across the stimulation conditions. Statistical testing with a linear mixed model and 
Kenward–Roger approximations revealed no significant effect for the simulation conditions, 
(F1,18 = 1.13, P = .3). However, the DVPRS and ODI data were not normally distributed as 
determined by the Kolmogorov–Smirnov tests for the null hypothesis that the data comes from a 
standard normal distribution (P = .005). We thus performed exploratory analysis with the 
Wilcoxon signed rank test, a nonparametric test for non-normally distributed data. We found a 
significant effect only for change in DVPRS (P = .0488; Fig 5A) and not a change in ODI 
(P = .17; Fig 5B). 
 
Figure 5. Changes in pain assessments (DVPRS and ODI) under stimulation conditions (tACS 
and sham). Statistical significance was assessed with the nonparametric Wilcoxon signed rank 
test (*P < .05). Red symbol indicates an outlier. 
Discussion 
Previous studies have shown that patients with chronic pain exhibit abnormal neuronal 
oscillations.46 In particular, alpha oscillations have been hypothesized to be involved in chronic 
pain.9, 25,45, 52 Yet, to our knowledge we are the first to examine whether noninvasive brain 
stimulation can enhance alpha oscillations and thereby improve symptoms of chronic pain. We 
performed a randomized, crossover, double-blind, sham-controlled clinical trial to examine the 
association between endogenous alpha oscillations and pain severity in patients with CLBP and 
the modulation of alpha oscillations by 10-Hz tACS. We found that endogenous alpha 
oscillations in the somatosensory region were negatively correlated with pain severity measured 
by the assessments for back pain (DVPRS) and perceived disability due to back pain (ODI). 
Bifrontal 10-Hz tACS targeting the somatosensory region successfully enhanced alpha 
oscillations compared to sham stimulation. Further, we found that changes of pain relief were 
correlated with changes of endogenous alpha oscillations in the frontal and somatosensory 
regions. Our findings of successful target identification and engagement of alpha oscillations by 
10-Hz tACS for patients with CLBP demonstrate the potential of tACS for treating pain by 
modulating neuronal oscillations. 
 
TCD has been proposed as a framework for understanding underlying mechanisms of chronic 
neurogenic pain.34 In agreement with this the framework, increased theta oscillations and 
slowing of the dominant spectral peak were consistently observed in previous studies.48, 49,53, 
56 A decreased inhibition of the thalamus seems to be linked to increased theta oscillations in 
patients with chronic neurogenic pain. However, a study failed to replicate these findings in 
patients with CLBP.50 In this study, they recruited patients with CLBP (duration of illness at 
least 1 year) and compared them with age- and sex-matched healthy participants. The authors did 
not find any significant difference in terms of increased theta oscillations and peak shift to lower 
frequency and concluded that differing pain locations may have caused the discrepancy. 
Interestingly, none of the patients with chronic neurogenic pain suffered from low back pain in 
previous studies that tested the TCD hypothesis.48, 49,53, 56 In contrast, our study focused on 
the strength of the alpha oscillation motivated by the inverse correlation between neuronal 
activity and alpha oscillation power. We hypothesized that alpha oscillations are reduced in 
CLBP because of disinhibition associated with pathologically increased cortical excitation in 
chronic pain,62 which indicates dysfunction of inhibitory neurotransmitters.61 Testing the TCD 
was not a goal of this study and thus a direct comparison of the results is not possible. Instead, 
our findings may represent a fundamental neurophysiological correlate of pain symptoms in 
patients with CLBP. In the view of translation to a population with neuropathic pain using our 
approach, theta oscillations may be targeted by theta-tACS. However, identifying the 
relationship between theta oscillations and pain intensity should be performed first to target and 
modulate abnormal theta oscillations. Once the relationship is consistent across patients with 
neuropathic pain, detailed spatial targeting can be applied based on the identified target region. 
 
Inspired by a previous study,19 which found the relationship between peak alpha frequency and 
pain sensitivity, we investigated this relationship in our data. We found no significant correlation 
between peak alpha frequency and the 2 pain assessments (DVPRS and ODI) at baseline 
(Supplementary Fig 2). This discrepancy may come from a differing population of participants 
because our study population consisted of patients with CLBP. In addition, patients with long-
term chronic pain may exhibit some degree of depression as a comorbidity15 thus we assessed 
Hamilton Depression Rating Scale (HAM-D) from all participants to investigate a relationship 
between pain severity and depression level. We found no significant correlation between HAM-
D scores and the 2 pain assessments (DVPRS and ODI) at baseline (Supplementary Fig 3). We 
only assessed HAM-D at baseline because tracking depression level was not a goal of this study. 
This relationship needs to be investigated further in a larger sample with multiple assessments. 
 
Deep brain stimulation that stimulates periventricular/periaqueductal gray matter, internal 
capsule, and sensory thalamus has shown promising improvement of pain relief.6, 47 Because of 
substantial risks of surgical implantation of electrodes in the brain, noninvasive brain stimulation 
techniques including rTMS have been investigated for the treatment chronic pain.28, 31,44 
Similar to our study, these studies considered chronic pain as a disorder associated with 
reorganization of the central nervous system.17 The first rTMS study showed that 10-Hz rTMS 
for 20 minutes applied to the motor cortex decreased pain severity in a sham-controlled clinical 
trial.30 A study with 1Hz-rTMS on the right somatosensory area also reduced pain compared to 
20Hz-rTMS and sham.16 Although these rTMS studies showed a substantial reduction in pain, 
several similar studies failed to replicate these findings. One study with 20-Hz rTMS found no 
significant differences between real and sham groups28 and another double-blind, sham-
controlled clinical trial with 1-Hz and 20-Hz rTMS found no significant treatment effects 
compared to sham stimulation.3 Recent meta-analysis showed that rTMS for treating pain does 
not achieve the minimum clinically important difference threshold of 15% or greater.41 In 
addition to rTMS, transcranial direct current stimulation (tDCS) has also been investigated. A 
recent meta-analysis found similar heterogeneity of outcomes for the tDCS studies.41 
 
It is of note that alpha oscillations have been investigated in depth in the context of pain stimuli 
in healthy control participants. Most of these studies have provided evidence for pain perception 
in presence of suppression of alpha oscillations for phasic pain.23, 36,38, 45 Likewise, longer-
lasting tonic pain, which may represent a precursor to chronic pain, suppressed alpha 
oscillations.13, 24,40, 52 In addition, pain severity and alpha oscillations were negatively 
correlated.40, 52 These studies are correlational in nature but a recent tACS study with 
behavioral outcome measures provided the first evidence for a causal role of alpha oscillation in 
pain processing4 albeit no confirmatory neurophysiological measurements were performed. Our 
study differed in scope and question since we examined target engagement of tACS by EEG and 
examined the causal role of alpha oscillations in the context of chronic pain. Such a target-
specific approach with EEG may provide a new insight to understand mechanisms of chronic 
pain. 
 
As any scientific study, our study has several limitations. First, we found a significant reduction 
for DVPRS only on exploratory analysis and none for ODI. One possible reason for this is that 
post-stimulation ODI was measured 2 days after each session because we hypothesized that a 
single session of tACS may not change disability. It is of note that our study was designed as a 
target engagement study with physiological changes including the alpha oscillation as primary 
outcome rather than treating chronic pain by a single session of tACS. The study was not 
designed or powered to detect meaningful clinical difference. Importantly, a treatment protocol 
would consist of repeated application of 10-Hz tACS as in our recent treatment clinical trial for 
auditory hallucinations in schizophrenia.37 In a follow-up study, we plan to investigate the 
treatment effect with lager sample size and more refined target engagement strategies such as 
individual alpha frequency.27, 54,59 Second, even though brain stimulation approaches have 
been used widely to modulate cortical excitability and treat patients, inter- and intra-individual 
variability for effects still exist.10, 35 Individualizing stimulation parameters with precise 
modeling of electric current density may be one approach to minimize variability. In our study, 
likewise, we fixed stimulation intensity and montage across all participants without 
individualization. In a follow-up study, individualization of stimulation parameters should be 
considered as well as multisession stimulation. 
 
In summary, we report on the first study of target identification and engagement with high-
density EEG and tACS for patients with CLBP. Our findings suggest a causal role of alpha 
oscillations in patients with CLBP. Targeting and modulating neuronal oscillations represents a 
promising strategy to understand the interaction between pain symptoms and brain oscillations. 
Potentially, such a target-specific approach to modulate pathologically impaired oscillations with 
tACS may provide therapeutic benefit for other disorders associated with brain network 
pathologies.  
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